Literature DB >> 34796457

Prevalence of Tuberculosis and Mental Disorders Comorbidity: A Systematic Review and Meta-analysis.

Gibril J Njie1, Awal Khan2.   

Abstract

Persons with tuberculosis (TB) also often have a mental disorder (MD). We examined TB-MD comorbidity prevalence and its impact on TB treatment outcomes as reported in studies set in the United States or in the top five countries of origin (Mexico, the Philippines, India, Vietnam, and China) for non-US-born persons with TB. We searched MEDLINE, EMBASE, OVID, PsycINFO, CINAHL, and Scopus for articles published from database inception through September 2018. Of the 9 studies analyzed, one was set in the United States. The estimated pooled prevalence of comorbid TB-MD from eight non-US studies, with 2921 participants, was 34.0% [95% confidence interval (CI) 21.1%-49.5%]. Comorbid TB-MD prevalence varied by country in the studies evaluated. Additional research might elucidate the extent of TB-MD in the United States and the top five countries of origin.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Mental disorders; Mental health; Treatment outcome; Tuberculosis

Year:  2021        PMID: 34796457      PMCID: PMC9114162          DOI: 10.1007/s10903-021-01312-6

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  36 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Screening for serious mental illness in the general population.

Authors:  Ronald C Kessler; Peggy R Barker; Lisa J Colpe; Joan F Epstein; Joseph C Gfroerer; Eva Hiripi; Mary J Howes; Sharon-Lise T Normand; Ronald W Manderscheid; Ellen E Walters; Alan M Zaslavsky
Journal:  Arch Gen Psychiatry       Date:  2003-02

3.  The DSM-5: Classification and criteria changes.

Authors:  Darrel A Regier; Emily A Kuhl; David J Kupfer
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

Review 4.  Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives.

Authors:  Claudia C Dobler; Greg J Fox; Paul Douglas; Kerri A Viney; Faiz Ahmad Khan; Zelalem Temesgen; Ben J Marais
Journal:  Eur Respir J       Date:  2018-07-11       Impact factor: 16.671

5.  Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.

Authors:  Molly F Franke; Sasha C Appleton; Jaime Bayona; Fernando Arteaga; Eda Palacios; Karim Llaro; Sonya S Shin; Mercedes C Becerra; Megan B Murray; Carole D Mitnick
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

6.  How to perform a meta-analysis with R: a practical tutorial.

Authors:  Sara Balduzzi; Gerta Rücker; Guido Schwarzer
Journal:  Evid Based Ment Health       Date:  2019-09-28

7.  Immigration to the USA and risk for mood and anxiety disorders: variation by origin and age at immigration.

Authors:  J Breslau; G Borges; Y Hagar; D Tancredi; S Gilman
Journal:  Psychol Med       Date:  2008-11-12       Impact factor: 7.723

8.  HIV-TB Coinfection among 57 Million Pregnant Women, Obstetric Complications, Alcohol Use, Drug Abuse, and Depression.

Authors:  Dorian Fernandez; Imoleayo Salami; Janelle Davis; Florence Mbah; Aisha Kazeem; Abreah Ash; Justin Babino; Laquiesha Carter; Jason L Salemi; Kiara K Spooner; Omonike A Olaleye; Hamisu M Salihu
Journal:  J Pregnancy       Date:  2018-01-01

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients.

Authors:  Argiro Pachi; Dionisios Bratis; Georgios Moussas; Athanasios Tselebis
Journal:  Tuberc Res Treat       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.